Evidence map›Paper›PMID 41195957›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026

Messages for ultraviolet-radiation protection to fair-skinned populations.

Lieve Brochez, Claus Garbe, Teresa Amaral, Petr Arenberger, Violeta Astratinei, Philippe Autier, Marianne Berwick, Matilda Bylaite, Brigitte Boonen, Veronique Del Marmol and 36 more

Abstract read
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors.

Lieve BrochezDepartment of Dermatology, Ghent University Hospital, Ghent, Belgium.ORCID https://orcid.org/0000-0001-6105-6719
Claus GarbeCentre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.ORCID https://orcid.org/0000-0001-8530-780X
Teresa AmaralCentre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.ORCID https://orcid.org/0000-0002-2516-5181
Petr ArenbergerDepartment of Dermatovenereology, Charles University Third Medical Faculty and University Hospital Kralovske Vinohrady, Prague, Czech Republic.ORCID https://orcid.org/0000-0002-7919-9619
Violeta AstratineiMelanoma Patient Network Europe, Uppsala, Sweden.
Philippe AutierInternational Prevention Research Institute (i-PRI), Dardilly, France.
Marianne BerwickUniversity of New Mexico Comprehensive Cancer Centre, Albuquerque, New Mexico, USA.
Matilda BylaiteFaculty of Medicine, Centre of Dermatovenereology, Clinic of Infectious Diseases and Dermatovenereology, Vilnius University, Vilnius, Lithuania.
Brigitte BoonenBelgian Cancer Foundation, Brussels, Belgium.
Veronique Del MarmolDepartment of Dermatology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Brigitte DrenoFrance Nantes University, Inserm 1302, INCIT, Nantes, France.ORCID https://orcid.org/0000-0001-5574-5825
Maria Concetta FargnoliSan Gallicano Dermatological Institute, IRCCS, Rome, Italy.
Adele C GreenPopulation Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Rüdiger GreinertSkin Cancer Centre, Laboratory for Molecular Cell Biology, Elbe Hospital Buxtehude, Buxtehude, Germany.
Axel HauschildDepartment of Dermatology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany.
Catherine A HarwoodDepartment of Dermatology, Barts Health NHS Trust and Centre for Cell Biology and Cutaneous Research Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University, London, UK.
Isabelle HoorensDepartment of Dermatology, Ghent University Hospital, Ghent, Belgium.
Lidija KandolfDepartment of Dermatology, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia.ORCID https://orcid.org/0000-0002-5221-5068
Roland KaufmannDepartment of Dermatology, Venerology and Allergology, Frankfurt University Hospital, Frankfurt, Germany.ORCID https://orcid.org/0000-0002-1614-694X
Nicole Kelleners-SmeetssGROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands.
Aimilios LallasFirst Department of Dermatology, School of Medicine, Faculty of Health Sciences, Aristotle University, Thessaloniki, Greece.ORCID https://orcid.org/0000-0002-7193-0964
Celeste LebbéUniversité Paris Cite, AP-HP Dermato-Oncology and CIC, Cancer Institute APHP, Nord Paris Cité, Paris, France.
Ulrike LeiterCentre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.ORCID https://orcid.org/0000-0002-8019-1577
Henry W LimDepartment of Dermatology, Henry Ford Health, Detroit, Michigan, USA.
Caterina LongoZienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Skin Cancer Centre, Reggio Emilia, Italy.
Joseph MalvehyDepartment of Dermatology, Hospital Clínic de Barcelona (Melanoma Unit), University of Barcelona, IDIBAPS, Barcelona & CIBERER, Barcelona, Spain.
David MorenoabMedical-&-Surgical Dermatology Service, Hospital Universitario Virgen Macarena, Sevilla, Spain.
Fredrik ÖstmanMelanoma Patient Network Europe, Uppsala, Sweden.
Giovanni PellacaniDepartment of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University, Rome, Italy.ORCID https://orcid.org/0000-0002-7222-2951
Ketty PerisDermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.ORCID https://orcid.org/0000-0003-1957-6600
Caroline RobertDepartment of Medical Oncology, Gustave Roussy and Paris Saclay University, Villejuif, France.
Bettina RyllMelanoma Patient Network Europe, Uppsala, Sweden.
Philippe SaiagDepartment of General and Oncologic Dermatology, Ambroise Paré Hospital, APHP, & EA 4340 "Biomarkers in Cancerology and Haematooncology", UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.
Dirk SchadendorfDepartment of Dermatology & West German Cancer Centre, University Hospital Essen & German Cancer Consortium & National Centre for Tumour Diseases (NCT)-West, Essen, Germany.ORCID https://orcid.org/0000-0003-3524-7858
Peter SoyerDermatology Research Centre, Frazer Institute, The University of Queensland, Brisbane, Queensland, Australia.
Gilliosa Spurrier-BernardMelanoma Patient Network Europe, Uppsala, Sweden.
Eggert StockflethDepartment of Dermatology, Ruhr-University, Bochum, Germany.
Alex StratigosFirst Department of Dermatology, University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece.
Hisashi UharaDepartment of Dermatology, Sapporo Medical University, Sapporo, Japan.ORCID https://orcid.org/0000-0001-5391-3397
Ricardo VieiraDepartment of Dermatology and Venereology, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal.
Martin A WeinstockBrown University and V A Medical Centre, Providence, Rhode Island, USA.
Dagmar WhitakerPrivate Practice, Cape Town, South Africa.
David C WhitemanPopulation Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Iris ZalaudekDepartment of Dermatology and Venereology of the Hospital Clinics Giuliano Isontino (ASUGI), Maggiore Hospital, Trieste, Italy.
Ana-Maria ForseaDermatology Department, Elias University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.ORCID https://orcid.org/0000-0002-1007-7883
EADO Task Force for Prevention and Early Detection of Skin Cancer

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSkin cancer prevention remains a critical public health challenge, particularly in fair-skinned populations in Europe, the United States and Australia, where incidence rates of keratinocyte skin cancer and melanoma continue to rise despite decades of public education on ultraviolet-radiation (UVR) protection. Although progress has been observed in Oceania, the overall effectiveness of current prevention strategies remains insufficient. This paper aims to refine and disseminate more effective UVR protection messages by developing an evidence-based, internationally adaptable public education leaflet.

methodsThe development of this educational material followed the current guidelines for the development of health promotion materials and effective public education. Based on the scientific evidence, a plain-language message has been drafted. It was subsequently revised through multiple rounds of multi-stakeholder feedback from dermato-oncology, epidemiology, public health experts, patient organizations representatives and NGOs involved in prevention and health promotion.

resultsThe final educational leaflet emphasizes three core messages: avoiding intentional sun exposure and tanning, utilizing shade and protective clothing as primary UV protection strategies and using sunscreen as a supplementary protective measure. Additional recommendations address childhood sun protection, the dangers of tanning beds and the importance of monitoring skin for early signs of cancer. Common concerns such as vitamin D synthesis and sunscreen safety are also addressed with evidence-based responses. DISCUSSION: This initiative highlights the necessity of shifting public attitudes towards UVR exposure and developing tailored, culturally sensitive communication strategies. The freely available leaflet will be distributed through professional associations and online platforms. Future efforts should involve policymakers in implementing structural changes, such as enhancing public shade availability and regulating tanning facilities, to promote long-term behavioural shifts in UV protection.

Indexed as

Health EducationSkin NeoplasmsSkin PigmentationUltraviolet RaysHealth PromotionHumansProtective ClothingSunscreening AgentsSunscreening Agentseducational materialsmelanomapatient education as topicphotoprotectionskin neoplasms/prevention & controlultraviolet rays/adverse effects

Identifiers

PMID41195957
PMCPMC13014430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.